What substances, foods, medications, and conditions should patients avoid while taking itraconazole?

What Patients Should Avoid While on Itraconazole

Patients taking itraconazole must avoid numerous medications that can cause life-threatening cardiac arrhythmias, severe toxicity, or treatment failure, with rifampin/rifabutin and vinca alkaloids being absolutely contraindicated. 1

Absolutely Contraindicated Medications (Life-Threatening Interactions)

Cardiac Medications - Risk of Fatal Arrhythmias

• Antiarrhythmics: Disopyramide, dofetilide, dronedarone, quinidine - these cause QT prolongation and torsades de pointes when combined with itraconazole 1
• Calcium channel blockers: Felodipine, nisoldipine 1
• Other cardiac drugs: Ivabradine, ranolazine, eplerenone 1

Neuropsychiatric Medications - Risk of Severe CNS Toxicity

• Opioids: Methadone (contraindicated due to QT prolongation and respiratory depression) 1
• Benzodiazepines: Oral midazolam, triazolam 1
• Antipsychotics: Pimozide, lurasidone 1
• Ergot alkaloids: Dihydroergotamine, ergotamine, methylergonovine - risk of severe vasospasm and ischemia 1

Chemotherapy Agents - Risk of Severe Neurotoxicity

• Vinca alkaloids (vincristine, vinblastine): Can cause peripheral neuropathy, seizures, and severe neurotoxicity - alternative antifungal therapy (amphotericin B or echinocandin) should be used instead 2, 1
• Irinotecan: Increased toxicity 1

Lipid-Lowering Agents

• Statins: Lovastatin, simvastatin (contraindicated due to rhabdomyolysis risk) 1

Other Contraindicated Medications

• GI motility: Cisapride (QT prolongation) 1
• Antimycobacterials: Rifampin/rifabutin - dramatically decrease itraconazole levels, rendering treatment ineffective 2, 1
• Other azoles: Isavuconazole 1
• Miscellaneous: Naloxegol, lomitapide, avanafil, ticagrelor, finerenone, voclosporin 1

Medications Requiring Dose Adjustment and Close Monitoring

Immunosuppressants - Critical for Transplant Patients

• Calcineurin inhibitors (tacrolimus, cyclosporine): Reduce dose by 30-50% when starting itraconazole and monitor levels closely to prevent toxicity while avoiding graft rejection 2
• mTOR inhibitors (sirolimus, everolimus): Require even greater dose reduction than calcineurin inhibitors 2

Corticosteroids

• All corticosteroids: Levels increase with azoles, potentially exacerbating immunosuppression and promoting fungal growth; prolonged use may cause Cushing's syndrome 2

Anticoagulants

• Warfarin/acenocoumarol: Itraconazole significantly increases anticoagulation effect with risk of overanticoagulation (INR >6); requires dose reduction and more frequent INR monitoring 3

Antiretroviral Agents

• HIV medications: Bidirectional interactions are common; therapeutic drug monitoring of itraconazole levels is recommended 2

Other High-Risk Medications

• Digoxin: Increased levels requiring monitoring 2
• Cyclophosphamide: Increased renal, hepatic, and genitourinary toxicity 2
• Tyrosine kinase inhibitors, macrolides, antiarrhythmics: All interact via CYP3A4 2
• Opioids not contraindicated (fentanyl, alfentanil, buprenorphine, oxycodone, sufentanil): Require dose reduction and monitoring for respiratory depression 1

Medical Conditions to Avoid or Monitor

Cardiac Conditions - Absolute Contraindication in Some Cases

• Congestive heart failure or history of CHF: Itraconazole has negative inotropic effects and should NOT be used except for life-threatening infections 1
• Conditions causing QT prolongation: Use with extreme caution in patients with cardiac disorders predisposing to arrhythmias 2

Hepatic Dysfunction

• Active liver disease: Monitor liver function in all patients; stop immediately if signs of hepatotoxicity develop (unusual fatigue, anorexia, nausea, vomiting, jaundice, dark urine, pale stools) 1

Renal Impairment

• Severe renal dysfunction: Contraindicated when combined with colchicine, fesoterodine, or solifenacin 1

Food and Medication Timing Considerations

Food Interactions - Critical for Absorption

• Itraconazole oral solution: Should be taken WITHOUT food when possible for optimal absorption 1
• Itraconazole capsules: Require food for absorption, but the TYPE of food matters significantly 4, 5
  • Bread/Western meals: Increase bioavailability significantly 4, 5
  • Rice meals: DECREASE bioavailability - avoid taking itraconazole after rice-based meals 4
  • High-fat meals: Promote absorption best 5

Gastric pH Modifiers

• Proton pump inhibitors and antacids: Decrease itraconazole capsule absorption by raising gastric pH; avoid concurrent use or separate timing significantly 2, 6

Common Pitfalls and Clinical Pearls

Therapeutic Drug Monitoring is Essential

• Target trough levels: 0.5-1.0 mg/L for itraconazole alone, or 1.0-2.0 mg/L for itraconazole plus hydroxy-itraconazole metabolite (when measured by bioassay, target is 3-17 mg/L) 2, 6
• Check levels at day 5-7 after starting therapy and repeat weekly initially 2
• Low levels are common due to variable absorption and predict breakthrough fungal infections 2

Real-World Prescribing Errors are Common

• A 2023 study found that solifenacin, clarithromycin, alfuzosin, and tamsulosin were frequently co-prescribed with itraconazole despite contraindications, with 31.3% of interactions carrying QT prolongation risk 7

Formulation Matters

• Oral solution and capsules are NOT interchangeable - they have different absorption profiles and food requirements 1

Hearing Loss Warning

• Transient or permanent hearing loss can occur, especially with concurrent quinidine use; patients should report any hearing changes immediately 1

Neuropathy Monitoring

• Discontinue itraconazole if peripheral neuropathy develops that may be attributable to the drug 1